The role of voice therapy in the treatment of dyspnea and dysphonia in a patient with a vagal nerve stimulation device - PubMed (original) (raw)
Case Reports
The role of voice therapy in the treatment of dyspnea and dysphonia in a patient with a vagal nerve stimulation device
Amanda I Gillespie et al. J Voice. 2014 Jan.
Abstract
Vagal nerve stimulators (VNS) are implanted to treat medically refractory epilepsy and depression. The VNS stimulates the vagus nerve in the left neck. Laryngeal side effects are common and include dysphagia, dysphonia, and dyspnea. The current case study represents a patient with severe dyspnea and dysphonia, persisting even with VNS deactivation. The case demonstrates the use of voice and respiratory retraining therapy for the treatment of VNS-induced dysphonia and dyspnea. It also highlights the importance of a multidisciplinary approach, including laryngology, neurology, and speech-language pathology, in the treatment of these challenging patients.
Keywords: Epilepsy; PVFMD; Respiratory retraining; Vagal nerve stimulation.
Copyright © 2014 The Voice Foundation. Published by Mosby, Inc. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical